Experience with Generic Pegylated L-asparaginase in Children with Acute Lymphoblastic Leukemia from a Tertiary Care Oncology Center in South India.

导出 LinkOut

翻译打印收藏纠错

作者： Dhaarani,Jayaraman ^[1] ; Latha M,Sneha ^[1] ; Gracelin,Jeyarani ^[1] ; Alekhya,Somayajula ^[2] ; Balaji Thiruvengadam,Kothandam ^[1] ; Julius Xavier,Scott ^[1] ; A,Gadekar ^[3]

作者单位： Division of Pediatric Hemato-Oncology, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India. ^[1] Department of Pediatrics, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India. ^[2] Emcure Pharma, Pune, Maharashtra, India. ^[3]

关键词 ALL Hamsyl L-asparaginase MRD acute lymphoblastic leukemia generic pegylated L-asparaginase hypersensitivity minimal residual disease pegaspargase

DOI 10.1055/s-0042-1759785

PMID 38130281

发布时间 2023-12-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

South Asian journal of cancer

2023年12卷4期

371-377页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Experience with Generic Pegylated L-asparaginase in Children with Acute Lymphoblastic Leukemia from a Tertiary Care Oncology Center in South India.

South Asian journal of cancer

相似文献

South Asian journal of cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Experience with Generic Pegylated L-asparaginase in Children with Acute Lymphoblastic Leukemia from a Tertiary Care Oncology Center in South India.

South Asian journal of cancer

相似文献

South Asian journal of cancer

相关期刊

检索历史清除